Skip to main content

Relay Therapeutics

Relay Therapeutics Inc is an American clinical-stage precision oncology company using computational and experimental technologies for drug discovery. The company utilizes its Dynamo platform to analyze protein motion and design targeted small molecule therapies for complex biological targets. Revenue is primarily derived from research collaboration agreements, licensing milestone payments, and investment funding as its drug candidates advance. Core end markets embrace oncology clinical care, targeted cancer research, and precision medicine sectors globally. Relay Therapeutics holds a specialized position in the biotechnology sector through its focus on protein dynamics for drug discovery. The company is headquartered in Cambridge, Massachusetts, and its common stock is listed on the Nasdaq Global Select Market.

9 of the funds FundTelligence covers report a position in Relay Therapeutics.

Legal name
Relay Therapeutics Inc
Sector
Health Care
Country
United States
Funds holding it
9
Exposure themes
Cancer, Precision Medicine & Genomics, Precision Oncology, Precision Therapeutics, Treatment, Women's Health

Funds holding Relay Therapeutics

Showing the 8 largest of 9 funds holding it.

Loading...